Diphtheria and Tetanus toxoids adsorbed

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Sanofi Pasteur, a Sanofi Company

Conditions

DiphtheriaHIV InfectionsPertussisTetanus

Phase 1

Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems

CompletedNCT00006066

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

End: 2006-06-30Target: 92Updated: 2021-11-01

Phase 3

Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old

CompletedNCT02089347

Sanofi Pasteur, a Sanofi CompanyDiphtheria, Pertussis, Tetanus

Start: 2014-03-31End: 2015-03-31Updated: 2017-05-30